| European Case Law Identifier: | ECLI:EP:BA:2006:T003002.20061009 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 09 October 2006 | ||||||||
| Case number: | T 0030/02 | ||||||||
| Application number: | 92908166.9 | ||||||||
| IPC class: | C12N 9/42 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Xylanase, corresponding recombinant DNA sequence, xylanase containing agent, and use of the agent | ||||||||
| Applicant name: | Novozymes A/S | ||||||||
| Opponent name: | Koninklijke DSM N.V. | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Objection to the change of representation by the appellant (overruled) Added matter (no) Novelty (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t020030eu1.html
Date retrieved: 17 May 2021